We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Samchully and TechniKrom Expands cGMP Oligonucleotide Manufacturing Systems
News

Samchully and TechniKrom Expands cGMP Oligonucleotide Manufacturing Systems

Samchully and TechniKrom Expands cGMP Oligonucleotide Manufacturing Systems
News

Samchully and TechniKrom Expands cGMP Oligonucleotide Manufacturing Systems

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Samchully and TechniKrom Expands cGMP Oligonucleotide Manufacturing Systems"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Samchully Pharm. Co., Ltd. and TechniKrom, Inc. announced that they have entered into an exclusive supply agreement on large scale oligonucleotide manufacturing systems.

Under terms of the agreement TechniKrom will offer its engineering, fabrication, and qualification services to supply 100-mmol scale cGMP oligosynthesis and HPLC equipment to Samchully.

“We are excited to select TechniKrom, well-known in the industry for supplying the highest quality HPLC systems and large scale oligosynthesizers; this will be a key component of our expansion project, targeting clients who are looking for mid-scale siRNA and aptamer supply; we believe it supports our continuing efforts to become a sole “integrated supplier” to drive down the costs of manufacturing for oligos, complementing our nucleoside monomer capability,” said Samchully Director of Business Development, Dr. Moon-Hee Kim.

TechniKrom has experienced significant growth in its oligonucleotide equipment business since 2004. “We are pleased to partner with an up and coming company like Samchully, who has proven-track record in nucleoside manufacturing and scale-up, to enable them to meet the growing demand for large scale oligonucleotide manufacturing,” said TechniKrom President, CEO and founder, Lou Bellafiore.

Advertisement